News

The stock’s rally comes as Coinbase pushes further into traditional finance.

A pair of companies delayed their IPOs, sending a ripple of anxiety through the US market as investors wait for Anthropic PBC’s hotly anticipated debut to materialize.

Oura's IPO targets a $12.8B-$14.1B valuation, pricing shares at $40-$44 ahead of its Nasdaq debut, backed by Eli Lilly interest and strong subscription revenue growth.

The health conscious smart ring-maker priced its offering at $40 to $44 a share.

Cognex (NASDAQ:CGNX) said it has entered into a definitive agreement to acquire RealSense, a provider of depth-sensing cameras and vision technology used in robotic perception and physical AI applications. The transaction is intended to expand Cognex’s machine-vision portfolio into 3D depth percept

Investor expectations have become concentrated at unprecedented scale

Both Paramount and Warner Bros. jumped on Monday after settling an antitrust lawsuit that could have blocked the merger.

Major crypto exchange Coinbase (NASDAQ: $COIN) is giving U.S. retail investors access to initial public offerings (...

Anthropic PBC is releasing a new artificial intelligence model that’s meant to field a wide range of business tasks at a lower cost, part of the startup’s bid to keep ahead of rivals while it prepares for a highly anticipated Wall Street debut.

Investing.com -- SB Energy’s multi-billion-dollar initial public offering is advancing according to plan, a person familiar with the matter told Investing.com, dispelling reports of a delay. However, the source did not explicitly state when the IPO would take place, noting only that internal preparations are proceeding as intended. The clarification follows SB Energy’s amended S-1 filing with the U.S. Securities and Exchange Commission (SEC) yesterday, which confirmed that preparations for listi

The Ryax deal gives Nutanix new tools to automatically determine where AI workloads should run, potentially helping enterprises use scarce, expensive computing resources more effectively.

Space Exploration Technologies has climbed 10.9% over the past month, putting fresh attention on whether a book value lens still lines up with where the stock trades today. With the share price at US$151.85 and fresh headlines around contracts, AI ambitions and possible tie ups, the question for many investors is how much of the balance sheet is already priced in. The 10.9% gain over the last 30 days raises the stakes for anyone asking whether recent momentum in Space Exploration...

Palantir is bringing its data playbook to Chipotle’s kitchens.

Westinghouse's coming IPO revival has a 63-year-old Social Security collector asking the wrong question. Whether the gain stops his monthly check is easy. Which tax return quietly absorbs it is where real money gets lost.

GameStop quietly disclosed a $4.9 billion eBay stake while 59 million warrants sit underwater with weeks until expiration, and whether Ryan Cohen can pull off the biggest retail comeback deal in history may hinge on a single stock price crossing one critical threshold.

With an antitrust lawsuit now settled, the controversial Hollywood megamerger is now likely to proceed quickly. Here’s what to expect.

The British AI data center developer depends on tech giants Microsoft and Anthropic for most of its revenue.

Accelevation Holdings Corp. and its backer Olympus Partners are seeking to raise as much as $720 million in the data center infrastructure company’s initial public offering.

J&J acquired Intra-Cellular in 2025 for $14.6bn, making it the largest pharma M&A deal in 2025.

Novo Nordisk (NYSE:NVO) is considering acquisitions to strengthen its weight-loss drug pipeline and expand into related therapeutic areas as competition increases, Chief Executive Mike Doustdar said on Tuesday. Speaking to CNBC’s Squawk Box Europe, Doustdar said the Danish pharmaceutical company was examining opportunities to address gaps in its portfolio, including acquiring medicines that could complement or outperform treatments developed internally.

Paramount Skydance Corp.’s (NASDAQ:PSKY) $110 billion acquisition of Warner Bros. Discovery, Inc. (NASDAQ:WBD) has cleared a major legal hurdle after the company reached a settlement with a coalition of U.S. states and the Writers Guild of America. Paramount Warner Bros. Discovery Merger Clears Antitrust Fight The settlement on Monday allows the merger to move forward while requiring Paramount to accept several conditions aimed at addressing concerns over competition, jobs and media concentratio

Nasdaq (NASDAQ:NDAQ) CFO Sarah Youngwood said the company sees a constructive macroeconomic backdrop, citing investment in artificial intelligence and digital technologies, resilient consumers and corporate earnings that she said are supporting market valuations. Speaking at a fireside chat with an

Iambic Therapeutics, Inc., an AI drug discovery company backed by Nvidia Corp. (NASDAQ:NVDA) and the Qatar Investment Authority, filed for an initial public offering, according to an S-1 filing with the SEC on Monday. Plans to List on Nasdaq, Under Ticker ‘IAM’ Iambic said it plans to use the IPO proceeds, along with its existing cash, to continue advancing its three cancer drug candidates through clinical development, with any remaining funds going toward general operating costs. It will go pub

Trade associations representing chemical and fertilizer shippers, among others, say the merger could negatively impact competition.

More government oversight could be better for humanity, but also serves to cover AI companies’ butts.

Shares of Warner Bros. Discovery rallied after Paramount Skydance reached a settlement paving the way for the media giants’ mega-merger.

Paramount Skydance (PSKY) has settled its antitrust lawsuit from several state attorneys general over its merger with Warner Bros. Discovery (WBD), as reported by the Wall Street Journal. Morningstar senior equity analyst Matthew Dolgin discusses what this means for Paramount's path forward in closing this deal.

Oura Inc. is pitching its U.S. initial public offering to investors, aiming for a fully diluted value of about $15.62 billion as it sizes up demand for consumer tech deals. The smart-ring maker plans to price next week, as markets...

Eligible customers can request shares at the offering price, but allocations are not guaranteed.

SpaceX's historic IPO cratered by nearly a third, yet 28 Wall Street analysts refuse to downgrade it. The question is whether the bull case rests on transformative compounding or on contracts that expire in 90 days.